The October 2012 edition of The Health Gazette Ezine has been published as scheduled on October 1st.
This month our main article, titled Health: Do you have the guts for it?, briefly explores the central importance of one’s resident intestinal microflora for health.
Subscription to the Ezine Edition is now CLOSED. We believe we have now removed or converted all subscription forms. This month’s Ezine also announces the availability for sale of the entire Tylee Health Education Network. Full details may be found on Flippa.
Current subscribers will find the ezine in their mailbox. It has been posted in the subscribers’ archive already.
The MedWatch August 2012 Safety Labeling Changes posting includes 53 products with safety labeling changes to the following sections: BOXED WARNINGS, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and PATIENT PACKAGE INSERT.
The “Summary Page” available via the link below provides a listing of drug names and safety labeling sections revised:
http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm315860.htm
The following drugs had modifications to the BOXED WARNINGS, CONTRAINDICATIONS and/or WARNINGS sections:
- Aplenzin (Bupropion Hydrobromide)
- Atrovent HFA (Ipratropium Bromide HFA)
- Avelox (Moxifloxacin Hydrochloride)
- Bactrim (Sulfamethoxazole and Trimethoprim)
- Capoten (Captopril)
- Coartem (Artemether/Lumefantrine)
- Complera (Emtricitabine, Rilpivirine, Tenofovir
- Diovan (Valsartan)Bactrim DS (Sulfamethoxazole and Trimethoprim)
- Diovan HCT (Valsartan/Hydrochlorothiazide)
- Disoproxil Fumarate)
- Edurant (Rilpivirine)
- Fuzeon (Enfuvirtide)
- Intelence (Etravirine)
- Invega Sustenna (Paliperidone Palmitrate)
- Isentress (Raltegravir)
- Lamictal (Lamotrigine) and Lamictal XR (Lamotrigine)
- Leustatin (Cladribine)
- Lovaza (Omega-3-Acid Ethyl Esters)
- Lucentis (Ranibizumab)
- Mirapex (Pramipexole Dihydrochloride) and Mirapex ER (Pramipexole Dihydrochloride)
- Moviprep (PEG-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate and Ascorbic Acid)
- Neoral Soft Gelatin (Cyclosporine)
- Neoral oral Solution (Cyclosporine)
- Nexavar (Sorafenib)
- Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP)
- Ortho Evra (Norelgestromin/Ethinyl Estradiol)
- Oxaliplatin (Oxaliplatin)
- Revatio (Sildenafil)
- Sanctura XR (Trospium Chloride)
- Sandimmune (Cyclosporine, USP)
- Selzentry (Maraviroc)
- Strattera (Atomoxetine Hydrochloride)
- Sustiva (Efavirenz)
- Toviaz (Fesoterodine Fumarate)
- Tradjenta (Linagliptin)
- Trobicin (Spectinomycin)
- Ultane and Ultane NovaPlus (Sevoflurane)
- Vectibix (Panitumumab)
- Viread (Tenofovir Disoproxil Fumarate
There are some very nasty drugs in this list. Remember, never have any drug unless it is absolutely necessary. Demand that any and every prescriber of a drug provides a completely satisfactory explanation to you about why you need a drug, what it is being prescribed to achieve, what risks it poses, what the likely side effects are, what serious side effects are possible and what alternatives exist.
Tags: FDA drug alerts, MedWatch
The September 2012 edition of The Health Gazette Ezine will be published as scheduled on September 1st.
This month our main article, titled Overcoming Autism, briefly explores the successful approaches to preventing and treating autism. Yes, it can be successfully treated.
We again repeat our announcement that subscription to the Ezine Edition is now CLOSED. We believe we have now removed or converted all subscription forms.
Current subscribers will find the ezine in their mailbox on publication. It will be posted in the subscribers’ archive around the same time.
The MedWatch July 2012 Safety Labeling Changes posting includes 41 products with safety labeling changes to the following sections: BOXED WARNINGS, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and PATIENT PACKAGE INSERT.
The “Summary Page” available via the link below provides a listing of drug names and safety labeling sections revised:
http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm314601.htm
The following drugs had modifications to the BOXED WARNINGS, CONTRAINDICATIONS and/or WARNINGS sections:
- Avinza (morphine sulfate) Extended-Release Capsules
- Butrans (buprenorphine) Transdermal System
- Dantrium (dantrolene sodium) Oral Capsule
- Dolophine (methadone hydrochloride) Tablets
- Duragesic (Fentanyl Transdermal System)
- Embeda (morphine sulfate and naltrexone hydrochloride) Extended-Release Capsules
- Exalgo (hydromorphone HCl) Extended-Release Tablets
- Kadian (morphine sulfate) Extended-Release Capsules
- Methadone hydrochloride Oral Solution and Concentrate
- MS Contin (Morphine Sulfate Controlled-Release) Tablets
- Nucynta ER (tapentadol) Extended-Release Oral Tablets
- Opana ER (oxymorphone hydrochloride) Extended-Release Tablets
- Oxycontin (oxycodone hydrochloride controlled-release) Tablets
- Truvada (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)
- AzaSite (azithromycin ophthalmic solution)
- Biaxin (clarithromycin)
- Diovan (valsartan) Tablets and Diovan HCT (valsartan/hydrochlorothiazide)
- Caduet (amlodipine/atorvastatin) Tablets
- Eraxis (anidulafungin) Powder for Injection
- Mirapex (pramipexole dihydrochloride)
- Natrecor (nesiritide) for Injection
- Prograf (tacrolimus) Capsules and Injection
- Sanctura (trospium chloride)
- Strattera (atomoxetine hydrochloride) capsules
- Zinecard (dexrazoxane) for injection
Always remember that ALL prescribed medicines are dangerous. Only prescribe or consume them if truly necessary. There are always adverse effects when taking drugs and not all are documented. If you have any unwanted reactions or responses to medication be sure to make a report.
Tags: FDA MedWatch
The August 2012 edition of The Health Gazette Ezine will be published as scheduled on August 1st.
This month’s edition points to am amazing discovery that unravels the mystery of the causes of the so-called diseases of civilization (DOC). You may have missed that. Yes, an intelligent, scientific and quite sound and trustworthy discovery has been made by an American professor of food science yet it is just possible that you are first hearing about it right here, right now. How can it possibly be that such a momentous discovery has been overlooked by the mainstream media? You would do well to ask that very question.
It turns out that a metabolite of a single environmental toxin that people become repeatedly exposed to in various forms is the causative agent in the development of diseases ranging from Alzheimer’s and multiple sclerosis, through various cancers and cardiovascular disease to rheumatoid arthritis and autism and more. What is more, this toxin is found in cigarette smoke and some foods and is entirely avoidable. It seems that one thing the world is not ready for is a dramatic advance towards health and wellness. There is just far too much vested interest in illness, disease and suffering. Sad, but all too true. All the details are in the August ezine edition.
We again repeat our announcement that subscription to the Ezine Edition is now closed. While most subscription forms have been removed it appears that we still have some remaining ones that we need to remove. This will be completed soon.
Current subscribers will find the ezine in their mailbox on publication. It will be posted in the subscribers’ archive around the same time.
Tags: diseases of civilization, DOC, Health Gazette Ezine, methanol